Charles Schwab Investment Management Inc Repligen Corp Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Repligen Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 363,379 shares of RGEN stock, worth $61.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
363,379
Previous 357,901 1.53%
Holding current value
$61.6 Million
Previous $45.1 Million 19.86%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$119.79 - $167.35 $656,209 - $916,743
5,478 Added 1.53%
363,379 $54.1 Million
Q2 2024

Aug 12, 2024
BUY
$120.0 - $182.95 $682,800 - $1.04 Million
5,690 Added 1.62%
357,901 $45.1 Million
Q1 2024

May 08, 2024
BUY
$170.78 - $208.42 $1.67 Million - $2.03 Million
9,759 Added 2.85%
352,211 $64.8 Million
Q4 2023

Feb 06, 2024
BUY
$114.17 - $185.35 $1.8 Million - $2.93 Million
15,785 Added 4.83%
342,452 $61.6 Million
Q3 2023

Nov 08, 2023
BUY
$138.78 - $176.51 $1.2 Million - $1.53 Million
8,667 Added 2.73%
326,667 $51.9 Million
Q2 2023

Aug 09, 2023
BUY
$138.42 - $180.31 $794,807 - $1.04 Million
5,742 Added 1.84%
318,000 $45 Million
Q1 2023

May 11, 2023
BUY
$154.26 - $198.1 $771,300 - $990,500
5,000 Added 1.63%
312,258 $52.6 Million
Q4 2022

Feb 13, 2023
BUY
$162.42 - $220.56 $2.01 Million - $2.73 Million
12,365 Added 4.19%
307,258 $52 Million
Q3 2022

Nov 14, 2022
BUY
$160.42 - $256.21 $165,232 - $263,896
1,030 Added 0.35%
294,893 $55.2 Million
Q2 2022

Aug 15, 2022
BUY
$140.68 - $188.02 $798,781 - $1.07 Million
5,678 Added 1.97%
293,863 $47.7 Million
Q1 2022

May 13, 2022
BUY
$161.19 - $257.96 $1.13 Million - $1.8 Million
6,992 Added 2.49%
288,185 $54.2 Million
Q4 2021

Feb 11, 2022
BUY
$247.59 - $304.47 $1.84 Million - $2.26 Million
7,421 Added 2.71%
281,193 $74.5 Million
Q3 2021

Nov 16, 2021
SELL
$194.77 - $324.21 $21.4 Million - $35.6 Million
-109,949 Reduced 28.65%
273,772 $79.1 Million
Q2 2021

Aug 16, 2021
BUY
$165.87 - $220.95 $1.53 Million - $2.04 Million
9,244 Added 2.47%
383,721 $76.6 Million
Q1 2021

May 17, 2021
SELL
$180.37 - $226.26 $2.08 Million - $2.61 Million
-11,544 Reduced 2.99%
374,477 $72.8 Million
Q4 2020

Feb 16, 2021
SELL
$148.08 - $206.57 $343,841 - $479,655
-2,322 Reduced 0.6%
386,021 $74 Million
Q3 2020

Nov 13, 2020
BUY
$122.51 - $158.27 $1.57 Million - $2.03 Million
12,830 Added 3.42%
388,343 $57.3 Million
Q2 2020

Aug 14, 2020
SELL
$94.33 - $140.48 $8.06 Million - $12 Million
-85,392 Reduced 18.53%
375,513 $46.4 Million
Q1 2020

May 15, 2020
BUY
$84.96 - $109.14 $1.76 Million - $2.26 Million
20,664 Added 4.69%
460,905 $44.5 Million
Q4 2019

Feb 07, 2020
BUY
$73.84 - $93.08 $564,506 - $711,596
7,645 Added 1.77%
440,241 $40.7 Million
Q3 2019

Nov 08, 2019
BUY
$76.65 - $95.51 $10.3 Million - $12.8 Million
134,383 Added 45.06%
432,596 $33.2 Million
Q2 2019

Aug 09, 2019
SELL
$54.2 - $85.95 $319,238 - $506,245
-5,890 Reduced 1.94%
298,213 $25.6 Million
Q1 2019

May 14, 2019
BUY
$49.45 - $62.8 $1.85 Million - $2.35 Million
37,458 Added 14.05%
304,103 $18 Million
Q4 2018

Feb 14, 2019
BUY
$48.26 - $68.88 $2.54 Million - $3.62 Million
52,626 Added 24.59%
266,645 $14.1 Million
Q3 2018

Nov 13, 2018
BUY
$46.8 - $58.97 $553,082 - $696,907
11,818 Added 5.84%
214,019 $11.9 Million
Q2 2018

Aug 08, 2018
BUY
$35.26 - $47.04 $415,503 - $554,319
11,784 Added 6.19%
202,201 $9.51 Million
Q1 2018

May 07, 2018
SELL
$30.92 - $37.27 $605,506 - $729,858
-19,583 Reduced 9.33%
190,417 $6.89 Million
Q4 2017

Jan 17, 2018
SELL
$32.53 - $38.92 $468,041 - $559,980
-14,388 Reduced 6.41%
210,000 $7.62 Million
Q3 2017

Nov 13, 2017
BUY
$36.98 - $46.06 $8.3 Million - $10.3 Million
224,388
224,388 $8.6 Million

Others Institutions Holding RGEN

# of Institutions
480
Shares Held
54.3M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.4B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email